Yenidoğan Konvulziyonları
Özet
Yenidoğan nöbetleri, bu dönemde en sık rastlanan nörolojik semptom olup çoğunlukla akut beyin hasarı ile ilişkilidir. Tanıda altın standart olan EEG monitorizasyonu sayesinde nöbetlerin hızlı tespiti ve sınıflandırılması, tedavi başarısını doğrudan etkilemektedir. Tedavide fenobarbital ilk basamak olarak tercih edilmekle birlikte, dirençli vakalarda etiyolojiye yönelik ilaçlar ve destekleyici yöntemler kullanılmaktadır. Erken tanı ve doğru yönetim, hipoksik-iskemik ensefalopati, genetik veya metabolik kaynaklı nöbetlerin yarattığı uzun vadeli nörogelişimsel riskleri azaltmada kritik öneme sahiptir.
Neonatal seizures are the most common neurological symptom in newborns and are frequently associated with acute brain injury. Accurate diagnosis and classification, primarily through EEG monitoring, are essential for determining effective treatment strategies. While phenobarbital remains the first-line therapy, management of refractory cases requires targeted pharmacological approaches based on the underlying etiology. Early intervention is crucial for minimizing long-term neurodevelopmental risks associated with hypoxic-ischemic encephalopathy, as well as genetic and metabolic conditions.
Referanslar
Abend NS, Jensen FE, Inder TE, Volpe JJ. Neonatal seizures. In: 's Neurology of the Newborn; 2018. p.275-321.
Shellhaas RA. Seizure classification, etiology, and management. Handb Clin NeuroL. 2019;162: 347-361.
Glass HC, Numis AL, Gano D, Bali V, Rogers EE. Outcomes after acute symptomatic seizures in children admitted to a neonatal neurocritical care service. Pediatr Neurol, 2018;84:39-45.
Pisani F, Spagnoli C. Acute symptomatic neonatal seizures in preterm neonates: etiologies and treatments. Semin Fetal Neonatal Med. 2018;23:191-196.
Tekgul H, Gauvreau K, Soul J, et al. The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics. 2006;117:1270–1280.
Silverstein FS, Jensen FE. Neonatal seizures. Ann Neurol. 2007;62:112–120.
Pisani F, Spagnoli C, Falsaperla R, Nagarajan L, Ramantani G. Seizures in the neonate: A review of etiologies and outcomes. Seizure. 2021 Feb;85:48-56.
Jensen FE. Neonatal seizures: an update on mechanisms and management. Clin Perinatol. 2009;36:881–900.
Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Med. 2009;5:380-391.
Nardou R, Ferrari DC, Ben-Ari Y. Mechanisms and effects of seizures in the immature brain. Semin Fetal Neonatal Med. 2013;18:175–184.
Dulac O, Milh M, Holmes GL. Brain maturation and epilepsy. Handb Clin Neurol. 2013;111:441–446.
Dzhala VI, Talos DM, Sdrulla DA, et al. NKCC1 transporter facilitates seizures in the developing brain. Nat Med. 2005;11: 1205–1213.
Sanchez RM, Jensen FE. Maturational aspects of epilepsy mechanisms and consequences for the immature brain. Epilepsia 2001;42:577–585.
Huttenlocher PR, de Courten C, Garey LJ, Van der Loos H. Synaptogenesis in human visual cortex—evidence for synapse elimination during normal development. Neurosci Lett. 1982;33:247–252.
Renée A. Shellhaas, Hannah C. Glass, and Taeun Chang. Neonatal seizures. In: Swaiman's Pediatric Neurology: Principles and Practice: Sixth Edition. Elsevier Inc; 2017. p. e318-330.
Clancy RR. Prolonged electroencephalogram monitoring for seizures and their treatment. Clin Perinatol. 2006;33:649–665.
Pressler RM, Cilio MR, Mizrahi EM, et al. The ILAE classification of seizures and the epilepsies: Modification for seizures in the neonate. Position paper by the ILAE Task Force on Neonatal Seizures. Epilepsia. 2021 Mar;62(3):615-628.
Gürbüz G, Ünalp A, Özbek E, et al. Etiological profile of the newborns who had convulsions and evaluation of their neurodevelopmental outcomes. İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi. 2015;5:43-47.
Rennie JM, Boylan GB. Seizure disorders of the neonate. In: Levene MI, Chervenak FA, editors. Fetal and neonatal neurology and neurosurgery. 4th ed. Philadelphia: Elsevier; 2009. p. 698e710.
Murray DM, Ryan CA, Boylan GB, Fitzgerald AP, Connolly S. Prediction of seizures in asphyxiated neonates: correlation with continuous videoelectroencephalographic monitoring. Pediatrics. 2006;118:41- 46.
Glass HC, Wusthoff CJ, Shellhaas RA et al. Risk factors for EEG seizures in neonates treated with hypothermia: a multi-center cohort study. Neurology. 2014;82:1–6.
Wusthoff CJ, Dlugos DJ, Gutierrez-Colina A, et al. Electrographic seizures during therapeutic hypothermia for neonatal hypoxicischemic encephalopathy. J Child Neurol. 2011;26:724-728.
Shellhaas RA, Chang T, Tsuchida T et al. The American clinical neurophysiology society’s guideline on continuous electroencephalography monitoring in neonates. J Clin Neurophysiol. 2011;28: 611–617.
Weeke LC, Groenendaal F, Toet MC et al. The aetiology of neonatal seizures and the diagnostic contribution of neonatal cerebral magnetic resonance imaging. Dev Med Child Neurol. 2015;57:248–256.
Glass HC, Shellhaas RA. Acute symptomatic seizures in neonates. Semin Pediatr Neurol. 2019;32:100768.
Glass HC, Shellhaas RA, Tsuchida TN, et al. Seizures in preterm neonates: a multicenter observational cohort study. Pediatr Neurol. 2017;72:19-24.
Tan AP, Svrckova P, Cowan F, et al. Intracranial hemorrhage in neonates: a review of etiologies, patterns and predicted clinical outcomes. Eur J Paediatr Neurol 22:690-717, 2018
Yıldız EP, Tatlı B, Ekici B, et al. Evaluation of etiologic and prognostic factors in neonatal convulsions. Pediatr Neurol. 2012;47:186-192.
Leventer RJ, Guerrini R, Dobyns WB. Malformations of cortical development and epilepsy. Dialogues Clin Neurosci. 2008;10:47.
Berg AT, Berkovic SF, Brodie MJ et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005–2009. Epilepsia. 2010;51:676–685.
Cornet MC, Cilio MR. Genetics of neonatal-onset epilepsies. Handb Clin Neurol. 2019;162:415-433.
Glass HC, Shellhaas RA, Wusthoff CJ et al. Contemporary profile of seizures in neonates: a prospective cohort study. J Pediatr. 2016;174:98–103.
Arican P, Dundar NO, Atasever NM, et al. Comparison of the neurocognitive outcomes in term infants treated with levetiracetam and phenobarbital monotherapy for neonatal clinical seizures. Seizure. 2020;80:71-74.
Soul JS. Acute symptomatic seizures in term neonates: etiologies and treatments. Semin Fetal Neonatal Med. 2018;23:183-190.
Van Hove JLK, Lohr NJ. Metabolic and monogenic causes of seizures in neonates and young infants. Mol Genet Metab. 2011;104:214e30.
Schmitt B, Baumgartner M, Mills PB, et al. Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine- dependent epilepsy and pyridoxine phosphate oxidase deficiency. Dev Med Child Neurol. 2010;52:e133–142.
Milh M, Villeneuve N, Chouchane M, et al. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations. Epilepsia. 2011;52:1828–1834.
Ramantani G, Schmitt B, Plecko B, et al. Neonatal Seizures—Are We there Yet?. Neuropediatrics. 2019;50:280-293.
Tsuchida TN, Wusthoff CJ, Shellhaas RA, et al. American clinical neurophysiology society standardized EEG terminology and categorization for the description of continuous EEG monitoring in neonates: report of the American Clinical Neurophysiology Society critical care monitoring committee. J Clin Neurophysiol. 2013;30:161-173.
Bhat V, Bhat V. Neonatal neurosonography: A pictorial essay. Indian J Radiol Imaging. 2014;24:389-400.
Weeke LC, Groenendaal F, Toet MC, et al. The aetiology of neonatal seizures and the diagnostic contribution of neonatal cerebral magnetic resonance imaging. Dev Med Child Neurol. 2015;57:248-256.
Fan G, Wu Z, Chen L, Guo Q, Ye B, Mao J. Hypoxia-ischemic encephalopathy in full-term neonate: correlation proton MR spectroscopy with MR imaging Eur J Radiol. 2003;45:91-98.
Ficicioglu C, Bearden D. Isolated neonatal seizures: when to suspect inborn errors of metabolism. Pediatr Neurol. 2011;45:283e91.
Jaume C, Plecko B. Treatable newborn and infant seizures due to inborn errors of metabolism. Epileptic Disord. 2015;17:229e42.
Sands TT, Choi H. Genetic testing in pediatric epilepsy. Curr Neurol Neurosci Rep. 2017;17:45.
Painter MJ, Scher MS, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. 1999;341:485-9.
Vento M, de Vries LS, Alberola A, et al. Approach to seizures in the neonatal period: a European perspective. Acta Paediatr. 2010;99:497e501.
Silverstein FS, Ferriero DM. Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol. 2008;39:77e9.
Kumar J, Meena J, Yadav J, Saini L. Efficacy and Safety of Phenobarbitone as First-Line Treatment for Neonatal Seizure: A Systematic Review and Meta-Analysis. J Trop Pediatr. 2021;67:fmab008.
Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A. 2004;101:9861–9866.
Sharpe C, Reiner GE, Davis SL, et al. Levetiracetam versus phenobarbital for neonatal seizures: a randomized controlled trial. Pediatrics. 2021;147(1):e2020036806.
Weeke LC, Schalkwijk S, Toet MC, van Rooij LG, de Vries LS, van den Broek MP. Lidocaine-associated cardiac events in newborns with seizures: incidence, symptoms and contributing factors. Neonatology. 2015;108:130e6.
Soul JS, Bergin AM, Stopp C, et al. A pilot randomized, controlled, double‐blind trial of bumetanide to treat neonatal seizures. Ann Neurol. 2021;89:327-340.
Pressler RM, Boylan GB, Marlow N, et al. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial. Lancet Neurol. 2015;14:469-477.
Stockler S, Plecko B, Gospe Jr SM, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab. 2011;104:48-60.
Gospe Jr SM. Neonatal vitamin-responsive epileptic encephalopathies. Chang Gung Med J. 2010;33:1-12.
Jensen KV, Frid M, Stödberg T, et al. Diagnostic pitfalls in vitamin B6 dependent epilepsy caused by mutations in the PLPBP gene. JIMD Rep. 2019;50:1-8.
Pisano T, Numis AL, Heavin SB, et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia. 2015;56:685–689.
Sands TT, Balestri M, Bellini G, et al. Rapid and safe response to low dose carbamazepine in neonatal epilepsy. Epilepsia, 2016;57:2019-2030.
Wolff M, Johannesen KM, Hedrich UBS, et al. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A related disorders. Brain. 2017;140:1316–1336.
Mikati MA, Jiang Y-H, Carboni M, et al. Quinidine in the treatment of KCNT1- positive epilepsies. Ann Neurol. 2015;78:995e9.
Okuda K, Yasuhara A, Kamei A, Araki A, Kitamura N, Kobayashi Y. Successful control with bromide of two patients with malignant migrating partial seizures in infancy. Brain Dev. 2000;22:56e9.
McTague A, Nair U, Malhotra S, et al. Clinical and molecular characterization of KCNT1-related severe early-onset epilepsy. Neurology. 2018;90:e55-e66.
Guillet R, Kwon J. Seizure recurrence and developmental disabilities after neonatal seizures: outcomes are unrelated to use of phenobarbital prophylaxis. J Child Neurol. 2007;22:389-395.
Fitzgerald MP, Kessler SK, Abend NS. Early discontinuation of antiseizure medications in neonates with hypoxic-ischemic encephalopathy. Epilepsia. 2017;58:1047-1053.
Glass HC, Grinspan ZM, Shellhaas RA. Outcomes after acute symptomatic seizures in neonates. Semin Fetal Neonatal Med. 2018;23:218-222.
